All News

Policy solutions were grouped around the themes of transparency, competition, and value. Healthcare heavyweights like Kaiser Permanente, AARP, and the American Hospital Association have signed on to the cause.

Patients diagnosed with advanced renal cell carcinoma, who have received prior treatment with anti-angiogenic agents, now have the option of being treated with the small molecule inhibitor cabozantinib.

It is not surprising that a new study on the relationship between income and longevity in the United States concludes that life expectancy increased with income. However, the study did shed light on the variabilities in the income-longevity relationship.

What we're reading, April 25, 2016: Marilyn Tavenner predicts steep Obamacare insurance premium hikes in 2017; the World Health Organization formally begins looking for its new leader; and the life expectancy between rich and poor young Americans narrows.

A diabetes drug may have benefits for people with chronic heart failure. Boehringer Ingelheim and Eli Lilly and Company have announced plans to investigate the use of the diabetes medicine Jardiance for heart failure with 2 outcome trials.

While healthcare for retirees once meant repeated trips to the doctor’s office, many are now able to receive high-quality medical services without leaving the comfort of home. And it’s all because of telemedicine.

The most important benefit of exercise was the improved ability of the men to fall asleep, the study found.

This week, the top stories in managed care included the news that UnitedHealth will be exiting most Obamacare exchanges in 2017, and coverage from both the annual meeting of the Academy of Managed Care Pharmacy and the Community Oncology Conference.

Fewer than 3% of Americans are active enough, eat a healthy diet, are nonsmokers, and have a healthy weight and percentage of body fat-the 4 important elements of a heart-healthy lifestyle that are promoted by the American Heart Association.

The state's first-in-the-nation waiver to Medicaid seemed endangered in late 2014, but Governor Asa Hutchinson decided keeping people insured was worth it.

The study showed the need to test children with type 1 disease for a lack of vitamin D.

Cost, biosimilars, and technology dominated the conversations when managed care pharmacists, health plan administrators, physicians, and more gathered for the AMCP Managed Care & Specialty Pharmacy Annual Meeting in San Francisco, April 19-22, 2016.

Stories on unsettling data on a rising suicide rate, Louisiana's Medicaid expansion efforts, and a Florida consumer education tool.

To have true utility, value models to assess the worthiness of treatments must have robust processes in place to incorporate the patient voice.

Flatiron Health has announced the development of a cloud-based electronic health record and an analytics tool to support reporting requirements for those clinics that will be selected to participate in the Oncology Care Model.

According to Avalere Health, physicians who prescribe lower cost drugs would be reimbursed at a higher rate than those who use more expensive drugs, under the proposed Medicare Part B demo model.

Since the study period ended, new results show a long-term cardioprotective benefit for empagliflozin and liraglutide.

The American Hospital Association is among those asking for a rating system that reflects socioeconomic differences in hospital populations.

What we're reading, April 21, 2016: Congress keeps things moving on the fight against the opioid epidemic; new paper from the National Bureau of Economic Research finds Medicaid expansion has a broader societal impact; and Novartis faces stiff competition from generic version of Gleevec.

What we're reading, April 20, 2016: Tufts Health Plan will pay for hepatitis C drugs for all patients with the disease; drug advertisements don't sway consumers; and Express Scripts countersues Anthem.

The health groups' letter comes after CSPI's February report, Carbonating the World, which spelled out global investment by Coca-Cola and PepsiCo.

The charges filed today are "only the beginning," according to Michigan's attorney general. Months of denial from state officials gave way when a pediatrician produced results showing elevated lead levels in children's blood.

An international study evaluating nivolumab in head and neck cancer has found that patients treated with the checkpoint inhibitor were twice as likely to be alive at 1 year after initiating treatment, compared with patients who were given standard chemotherapy.

What we're reading, April 19, 2016: blood-testing laboratory Theranos is now facing a criminal investigation; biosimilars may not be cheaper than brand name biologics for some seniors; and stigma and misconceptions remain regarding palliative care.

A study presented at the ongoing annual meeting of the American Association for Cancer Research has confirmed that 3 commercially available diagnostic tests that measure the expression of the programmed death ligand 1 protein in non-small cell lung cancer could be interchanged.

A cost-economic analysis by researchers at the Yale School of Public Health has found that switching to Gardasil-9, which protects against 9 oncogenic serotypes of the human papillomavirus, would provide improved health benefits at the same or lower societal cost.

UnitedHealth Group started the year in 34 insurance exchanges, but that number will be a lot less come 2017. CEO Stephen Hemsley announced that the company will only participate in a "handful" of Affordable Care Act exchanges next year.

Narrative often shapes a person’s approach to healthcare decisions, yet narrative is usually excluded from the medical evidence base, and it rarely plays a role in original research reports.

Early reports to the state's largest newspaper resemble tales from the days of Medicaid transitions in other states. While managed care may be better for accountability measures over the long haul, in state after state, large-scale transitions prove difficult.